shahin mohammed
banner
shahsonride.bsky.social
shahin mohammed
@shahsonride.bsky.social
Nephrologist. Dad. NSMC intern class of 2024. Here for ultrafiltration.
Reposted by shahin mohammed
Register NOW for #ISNCON25
✅ Conference Registration isncon2025lucknow.com/registration
✅ Workshop Registration
www.isncon2025.com/workshop-registration
Pre-Conf Workshop -Critical Care Nephrology & POCUS -18th Dec 2025
📌 Free Registration for the Workshop! (But you must register for the Conference)
October 21, 2025 at 7:55 AM
Reposted by shahin mohammed
We are nephrologists. Hyperkalemia is what scares endocrinologist and cardiologists.

we have the knowledge and the tools to manage this problem in this era when using the combo #NephJC
July 9, 2025 at 1:46 AM
Reposted by shahin mohammed
Reposted by shahin mohammed
🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social

⏰Chat happening on July 8, 9 pm EST

www.nephjc.com/news/2025/7/...
CONFIDENCE Visual Abstract — NephJC
Check out the beautiful visual abstract made by NephJC intern Michelle Fravel .
www.nephjc.com
July 7, 2025 at 8:00 PM
Reposted by shahin mohammed
With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?'

#NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social

#MedSky

www.nephjc.com/news/confide...
A dose of CONFIDENCE: Building evidence for finerenone-empagliflozin synergy in diabetic kidney disease — NephJC
This week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD.
www.nephjc.com
July 8, 2025 at 1:48 AM
🔥 BKV Infection in Kidney Transplant Recipients- A major threat to graft survival!

🎤 Don’t miss this exclusive webinar by @isn-india.bsky.social & @ttsorg.bsky.social featuring international experts🌍

🗓 8th May 2025
⏰ 7:30 PM IST

🔗 Register now: tinyurl.com/sueuuth6

@arvindcanchi.bsky.social
May 1, 2025 at 9:38 AM
🎤#ISNCON2025 Preconference workshops :
🗓️18 Dec | Top faculty 🌏
🔹Intervention Nephrology
🔹Critical Care + POCUS
🔹Onconephro & Histopath
🔹Pediatric Nephrology 👶
🔹Transplant Immunology
✅ Free for delegates
⏳ Limited seats! Hurry! ➡️ 🔗 isn-india.org/isn_registrati… @isn-india.bsky.social
April 19, 2025 at 11:09 AM
#ISNCON2025 Lucknow Awaits!
🎖️India's Premier #Nephrology Event by @isn-india.bsky.social

🤞🏽Learn ∙ 🤝 Connect ∙ 🌟 Grow
📢 Early bird discounts (Hurry!)
🎓 50% off for students
🔗 Register now: isn-india.org/isn_registrati… @arvindcanchi.bsky.social @kajareeg.bsky.social @jasminenephro.bsky.social
April 16, 2025 at 9:32 AM
🚨 Don’t miss out!
🎤 Present your work at @isn-india.bsky.social ’s flagship #ISNCON2025 in Lucknow! ✨
📢 Abstracts accepted now→ Published in 📖 IJN Publications. 🔗 Submit here 👉 isn-india.org/isn_registra...
@arvindcanchi.bsky.social @kajareeg.bsky.social @jasminenephro.bsky.social
April 15, 2025 at 10:00 AM
Reposted by shahin mohammed
Hey #NephSky & #MedSky
9pm EST 4/15/25, only on #Bluesky
Discussion on the use of metformin in advanced CKD.
Worried about lactic acidosis 💪?!
What's the evidence that an eGFR < 30 ml/min is the ideal cutoff ✂️?
Are there benefits to continuing 💊
www.nephjc.com/news/metformin-tte
Metformin- Should I Stay or Should I Go — NephJC
This week, we will discuss another target trial emulation study. The FDA says to stop metformin at a GFR of 30. Are they right?
www.nephjc.com
April 15, 2025 at 2:33 AM
Reposted by shahin mohammed
Not all cystic kidneys = ADPKD!
Inherited & acquired mimics exist.
Don’t miss infographic by @drpallaviprasad.bsky.social! #NephJC
March 26, 2025 at 1:17 AM
Reposted by shahin mohammed
Added an addendum to this chapter:

www.rosebook.club/blog/2025/3/...
March 25, 2025 at 4:36 PM
Reposted by shahin mohammed
We are discussing the @kdigo.org ADPKD guidelines tomorrow on #NephJC

Perfect timing for @jama.com to drop this review

jamanetwork.com/journals/jam...

($ub required sadly 🔒)

#NephSky
A Review of Autosomal Dominant Polycystic Kidney Disease
This review discusses the pathophysiology, clinical presentation, diagnosis, treatment, and prognosis of autosomal dominant polycystic kidney disease diagnosed in adulthood.
jamanetwork.com
March 24, 2025 at 4:08 PM
Reposted by shahin mohammed
March 12, 2025 at 1:07 AM
Reposted by shahin mohammed
Aha! And here's a bit about that trial (Regency/Obinutuzumab) from the one of the lead authors Dr Brad Rovin ( he's not on @bsky.app yet 🤔) #nephjc
youtu.be/DnMnTpCbFQY
WCN'25 interview with Brad Rovin by Arvind Canchi
YouTube video by International Society of Nephrology
youtu.be
March 11, 2025 at 3:12 PM
Reposted by shahin mohammed
👋See you tonight (😉hope you've read the supplement) #nephjc

⏰ 9 pm EST as always

🔔For people outside North America, be mindful of timezone difference (daylight savings)
March 11, 2025 at 4:12 PM
Reposted by shahin mohammed
1/10
Last #NephJC we continued our Aldo streak as we discussed mineralocorticoid antagonist (MRA) withdrawal before ✅aldosterone renin ratio (ARR) & adrenal vein sampling (AVS) #NephSky #MedSky
#TenPostNephJC makes this #Endosky oriented topic easy.
pubmed.ncbi.nlm.nih.gov/39660429/
March 9, 2025 at 8:38 AM
Reposted by shahin mohammed
It's March, 2 days before #WorldKidneyDay, so tonight there is the perfect opportunity to celebrate ( 9 pm Eastern, on 🦋)🌺🌻 #NephJC

🎨Until then, take a look at this beautiful and colorful #visualabstract made by Divya Bajpai

www.nephjc.com/news/2025/3/...
Obinutuzumab in lupus nephritis: The REGENCY Trial Visual Abstract — NephJC
Is Obinutuzumab Effective and Safe in Active Lupus Nephritis?&nbsp; Check out the beautiful VA by NSMC Faculty Dr Divya Bajpai on&nbsp;the REGENCY Trial, answering the same.
www.nephjc.com
March 11, 2025 at 7:23 AM
Reposted by shahin mohammed
Excited to see this finally in press!
Special thanks to @hswapnil.medsky.social for invitation and coauthors Abdulghani Kabli, Oleksa Rewa, Ted Clark. #canada. Special thanks to my role models Etienne Macedo and Ravi Mehta whose prior version we built upon.
#nephsky #medsky #emimcc
rb.gy/8kke9h
Continuous Kidney Replacement Therapies: Core Curriculum 2025
Critically ill patients that require kidney replacement therapy (KRT) are among the most ill and complex patients routinely encountered in the intensi…
sciencedirect.com
March 9, 2025 at 9:55 PM
Reposted by shahin mohammed
Reposted by shahin mohammed
Announcing the #NephJC internship, @nephjc.bsky.social and @kireports.bsky.social joining forces

www.nephjc.com/intern-app for details and to apply!

#NephSky
NephJC Editorial Internship — NephJC
www.nephjc.com
March 6, 2025 at 6:16 PM